+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

From
Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Hereditary Angioedema (HAE) Therapeutics Market 2024-2028 - Product Thumbnail Image

Hereditary Angioedema (HAE) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 161 Pages
  • Global
From
Topical Corticosteroids Market 2024-2028 - Product Thumbnail Image

Topical Corticosteroids Market 2024-2028

  • Report
  • July 2024
  • 164 Pages
  • Global
From
Autoimmune Drugs Market 2024-2028 - Product Thumbnail Image

Autoimmune Drugs Market 2024-2028

  • Report
  • July 2024
  • 185 Pages
  • Global
From
Primary Immunodeficiency Therapeutics Market 2024-2028 - Product Thumbnail Image

Primary Immunodeficiency Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 136 Pages
  • Global
From
HIV Treatment Drugs Market in Africa 2024-2028 - Product Thumbnail Image

HIV Treatment Drugs Market in Africa 2024-2028

  • Report
  • July 2024
  • 162 Pages
  • Africa
From
Immunosuppressants Market 2024-2028 - Product Thumbnail Image

Immunosuppressants Market 2024-2028

  • Report
  • July 2024
  • 138 Pages
  • Global
From
Scleroderma Therapeutics Market 2024-2028 - Product Thumbnail Image

Scleroderma Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 130 Pages
  • Global
From
HIV Drugs Market 2024-2028 - Product Thumbnail Image

HIV Drugs Market 2024-2028

  • Report
  • July 2024
  • 164 Pages
  • Global
From
Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 145 Pages
  • Global
From
Hyaluronic Acid Raw Material Market 2024-2028 - Product Thumbnail Image

Hyaluronic Acid Raw Material Market 2024-2028

  • Report
  • June 2024
  • 149 Pages
  • Global
From
Glucosamine Market 2024-2028 - Product Thumbnail Image

Glucosamine Market 2024-2028

  • Report
  • June 2024
  • 134 Pages
  • Global
From
Atopic Dermatitis Drugs Market 2024-2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market 2024-2028

  • Report
  • May 2024
  • 175 Pages
  • Global
From
Hyaluronic Acid Market 2024-2028 - Product Thumbnail Image

Hyaluronic Acid Market 2024-2028

  • Report
  • May 2024
  • 180 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market 2024-2028 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 174 Pages
  • Global
From
Allergy Immunotherapies Market 2024-2028 - Product Thumbnail Image

Allergy Immunotherapies Market 2024-2028

  • Report
  • May 2024
  • 167 Pages
  • Global
From
Immunoglobulin Products Market 2024-2028 - Product Thumbnail Image

Immunoglobulin Products Market 2024-2028

  • Report
  • May 2024
  • 169 Pages
  • Global
From
Plasma Protease C1 Inhibitor Market 2024-2028 - Product Thumbnail Image

Plasma Protease C1 Inhibitor Market 2024-2028

  • Report
  • January 2024
  • 166 Pages
  • Global
From
Urticaria Drugs Market 2024-2028 - Product Thumbnail Image

Urticaria Drugs Market 2024-2028

  • Report
  • January 2024
  • 167 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more